Urology Times staff

New products and services from ProUroCare, Touch of Life Technologies, and MDxHealth.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase I-III overactive bladder trials and phase IV BPH trials that are currently recruiting participants. This list is current as of April 19, 2012. For more information, view the complete database at http://ClinicalTrials.gov.

The newest urology products and services from Olympus, Teleflex, Inc., Medline Industries, Inc., and Wiley-Blackwell.

Urologists agree that PSA screening will be the hot topic at the AUA annual meeting in Atlanta.

New urology products and services on the horizon.

Newly available urology products and services.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV erectile dysfunction trials that are currently recruiting participants. This list is current as of March 17, 2010.

Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease.

The National Association for Continence (NAFC) is calling for stricter health care standards for patients with pelvic floor dysfunction, including incontinence and prolapse in women.

Having trouble with a patient who refuses to pay his account balance? Learn about your options.

Educate your patients about urinary tract infection with a free, customizable handout.

In children with recurrent urinary tract infections, low-dose, continuous oral antibiotic therapy may help prevent future recurrences.

Using an extremely sensitive tool based on nanotechnology, researchers from Northwestern University, Chicago say they have detected previously undetectable levels of PSA in patients who have undergone radical prostatectomy.

The FDA has approved GlaxoSmithKline's pazopanib (Votrient) to treat patients with advanced renal cell carcinoma.

Information on new products from Accuray Inc., Covidien, Harvard Apparatus, EMG Productions, and KeyScan Inc.

Educate your patients about erectile dysfunction with a free, customizable handout.

Cardiometabolic disorders and urologic disease represent a "perfect storm" of ailments, according to Kevin T. McVary, MD, who discusses the urologist's role in management.

New urology products and services from Roche, Accuray Inc., American Medical Systems, Boston Scientific, Primal Pictures, Life-Tech, and Mpathy Medical.

Urology Times wants your stories.

Information on new products from Endo Pharmaceuticals, Envisionier Medical Technologies, biolitec, Inc., and Mission Pharmacal.

Dr. Jordan Dimitrakov discusses the use of memantine in chronic pelvic pain syndrome with Urology Times.

Dr. Williams and Dr. Nangia discuss the effects of cardiometabolic disorders in aging men.

A look at new products and services from Karl Storz Endoscopy-America, Eloquest Healthcare, Abbott Laboratories, and Spectrum Surgical.

A look at urology drugs and devices in the pipeline.

New products from Uvision, Caldera Medical, Serono, Lumenis, American Medical Systems, and more.

AUA has addressed a number of questions and controversies concerning small renal masses in a new clinical guideline reflecting current research. Steven C. Campbell, MD, PhD, guideline co-chair, discusses the rationale for the guideline and key recommendations.

New Products & Services

I've never used them. I didn't even know they existed.